Routine Preoperative Screening for HIV, Hepatitis B, and Hepatitis C Before Elective Surgery
Routine universal preoperative screening for HIV, hepatitis B, and hepatitis C is not recommended before elective surgery in low-prevalence areas; instead, implement universal precautions for all patients and perform risk-based screening only when specific risk factors are identified or when results would change perioperative management.
Evidence-Based Rationale Against Universal Screening
The available guideline evidence does not support routine universal screening for bloodborne pathogens before elective surgery in most clinical settings:
Universal precautions are the cornerstone of protection. A study from San Francisco demonstrated that knowing HIV status made no difference in the incidence of sharps injuries when universal precautions were properly implemented, and additional precautions in operating theatres are not considered universally necessary in areas of low HIV prevalence 1.
Screening does not reduce transmission risk to healthcare workers. The risk of HIV seroconversion after a single needlestick injury with known HIV-infected blood is approximately 0.36%, and proper barrier precautions—not knowledge of patient status—prevent transmission 1.
Detection rates are extremely low in unselected populations. A 10-year retrospective study of 10,011 screened surgical patients found only 4 newly diagnosed infections (0.4‰ or 0.04%), making routine screening economically unjustifiable 2.
Cost-effectiveness is poor. The cost per positive result for universal HCV screening in elective craniotomy patients was $3,877 (95% CI $2,348–$11,119), compared to $226 for screening only patients with smoking history and $72 for those with IV drug abuse history 3.
When Screening IS Indicated
High-Prevalence Geographic Areas
- In areas of high HIV or hepatitis prevalence, all patients admitted for emergency surgery should be considered high risk, and preoperative screening should be considered essential 1.
Specific Risk-Based Indications
Hepatitis B screening should be performed on high-risk patients undergoing major abdominal, orthopaedic, or gynaecological surgery, and should be considered for all patients having open heart surgery where risks of blood exposure are considerable 1.
Screen patients with identifiable risk factors, including: homosexual or bisexual males, intravenous drug abusers, persons with penetrative sexual contact with others from high-prevalence areas, recipients of unscreened blood transfusions, haemophilic patients who received untreated blood products, sexual partners of any of the above, and children born to seropositive mothers 1.
Transplant and Blood Product Donation
- HIV antibody tests are required for infection control before surgery in transplant donors and before blood, sperm, or milk donation in accordance with Department of Health guidelines 1.
Alternative Approach: Risk-Factor Screening
A targeted screening strategy based on clinical history is more cost-effective and equally safe:
Take a careful history including questions about sexual behaviour, drug abuse, travel to HIV endemic areas, and hepatitis B risk factors; occasionally physical signs such as needle puncture sites may help detect high-risk behaviour 1.
For hepatitis C specifically, screening patients with a history of smoking reduces cost per positive result to $226, and screening those with IV drug abuse history reduces it to $72, compared to $3,877 for universal screening 3.
Recent evidence supports expanded risk-based testing for populations including persons incarcerated or formerly incarcerated, those with history of sexually transmitted infections or multiple sex partners, and those with history of hepatitis C virus infection 4.
Universal Precautions: The Primary Protection Strategy
All surgical teams must implement standard precautions for every patient, regardless of known infection status:
- Apply basic hygienic practices with regular hand-washing 1.
- Cover existing wounds and skin lesions with waterproof dressings 1.
- Protect mucous membranes of eyes, mouth, and nose from blood splashes 1.
- Never pass sharps hand to hand, never use hand needles, never guide needles with fingers, and never resheath needles 1.
- Dispose of all sharps safely into approved containers 1.
- Consider double gloving for high-risk procedures, though this is advocated only for high-risk patients due to loss of sensitivity 1.
Surgeon Protection: Vaccination, Not Screening
The most effective protection for healthcare workers is hepatitis B vaccination, not patient screening:
All surgeons should be immunised against hepatitis B, and if their subsequent antibody level is greater than 100 IU they should be given a booster dose three to five years later 1.
The risk of hepatitis B transmission to a properly vaccinated healthcare worker who has demonstrated an immune response is virtually zero, even after needlestick injury with HBV-contaminated blood 5.
Without vaccination, the risk of HBV transmission after a single needlestick exposure to HBeAg-positive blood may exceed 30%, compared to HIV risk of 0.36% 1, 5.
Clinical Management When Screening Is Performed
If screening is performed based on risk factors or clinical indication:
HIV testing should only be done after counselling and after informed consent has been obtained 1.
The other justification for screening is to benefit clinical management: early detection of asymptomatic HIV infection allows prompt treatment with antiretroviral therapy and prophylaxis against opportunistic infections 1.
For positive results, ensure proper referral pathways are established; in one study of surgical HCV screening, only 37.3% of anti-HCV positive patients received confirmatory HCV RNA testing, and referral rates varied dramatically by surgical department (76.6% in hepatobiliary surgery vs. 25.0–33.5% in other departments) 6.
Common Pitfalls to Avoid
Do not assume screening protects staff—universal precautions are equally necessary regardless of known patient status, and screening creates false security 1.
Do not screen without consent—HIV testing requires counselling and informed consent 1.
Do not fail to follow up positive results—screening is worthless if positive patients are not referred for treatment; establish clear referral pathways before implementing any screening program 6.
Do not place high-risk patients at the end of the operating list—this practice is unnecessary when proper precautions are used 1.
Do not neglect surgeon vaccination—hepatitis B vaccination of surgical staff is far more cost-effective than patient screening 1, 5.